(Press-News.org) Opioids appear to be associated with more adverse events among older adults with arthritis than other commonly used analgesics, including coxibs and non-steroidal anti-inflammatories, according to a report in the December 13/27 issue of Archives of Internal Medicine, one of the JAMA/Archives journals. In a second report assessing only opioid use, different types of drugs within the class were associated with different safety events among older patients with non-malignant pain.
"In the United States, one in five adults received a prescription for an analgesic in 2006, accounting for 230 million prescription purchases; however, the comparative safety of these drugs is unclear," the authors write as background information in one of the articles. "Although the cardiovascular safety of nonselective nonsteroidal anti-inflammatory drugs (nsNSAIDs) and selective cyclooxygenase-2 inhibitors (coxibs) has been called into question, there is little comparable information about the third major analgesic group, opioids."
In the first report, Daniel H. Solomon, M.D., M.P.H., and colleagues at Brigham and Women's Hospital, Boston, examined the comparative safety of nsNSAIDs, coxibs and opioids among 12,840 Medicare beneficiaries who received at least one of these analgesics between 1999 and 2005. Using data from a large health care utilization (claims) database, the authors evaluated the occurrence of cardiovascular events (heart attacks, stroke and heart failure, among others), gastrointestinal events (GI tract bleeding and bowel obstruction), acute kidney injuries, toxic effects on the liver, as well as falls and fractures.
Opioid users experienced higher rates for most types of serious adverse events than patients taking coxibs or nsNSAIDs, and nsNSAID users experienced the lowest risks. For example, fractures occurred among 101 per 1,000 opioid users per year, compared with 19 per 1,000 per year among coxib users.
Coxibs and opioids appear to be associated with greater cardiac risks than nsNSAIDs, but use of opioids and not coxibs was associated with a greater risk of hospitalization or death than use of nsNSAIDs. Conversely, the risk of gastrointestinal tract bleeding was reduced among those taking coxibs (12 per 1,000 per year, compared with 21 per 1,000 per year among those taking nsNSAIDs).
"Analgesics are used daily by millions of people; however, current data do not allow patients or physicians to determine which type of agent is safest. We compared nsNSAIDs, coxibs and opioids across a wide range of specific safety events and several composite safety events," the authors write. "Although nsNSAIDs pose certain risks, these analyses support the safety of these agents compared with other analgesics. The recent concerns raised about opioid use in non-malignant pain syndromes appear warranted on the basis of these data."
In a second article, Dr. Solomon and colleagues at Brigham and Women's Hospital studied only those Medicare beneficiaries who received opioids for non-malignant pain between 1996 and 2005. They compared the rates of adverse events after 30 and 180 days among 6,275 patients each taking one of five types of opioids: codeine, hydrocodone, oxycodone, propoxyphene and tramadol.
The risk of gastrointestinal adverse events remained similar for all the medications studied, and thirty days after beginning opioid therapy, the risk of cardiovascular events was also similar across all types. However, after 180 days, the risk of cardiovascular events was increased among those taking codeine. With hydrocodone as the reference point, risk of fracture was 79 percent lower among those taking tramadol and 46 percent lower among those taking propoxyphene. Compared with those taking hydrocodone, death from any cause was 2.4 times as likely among those taking oxycodone and twice as likely among those taking codeine.
"This study's findings do not agree with a commonly held belief that all opioids are associated with similar risk," the authors write. "The risks were not explained by the dosage being prescribed and did not vary across a range of sensitivity analyses. The risks were substantial and translated into numbers needed to treat that would be considered clinically significant. Our findings regarding cardiovascular risk were surprising and require validation in other data sets."
Proving a cause-and-effect relationship between types of opioids and adverse events requires an experimental rather than observation study design, they note, "but these results should prompt caution and further study."
In addition, a research letter, published in the same issue, found double the risk of cardiovascular events among patients followed for a median (midpoint) of 189 days after they stopped taking the analgesic drug rofecoxib during off-drug follow-up of a clinical trial. Joseph S. Ross, M.D., M.H.S., of Yale University School of Medicine, and colleagues analyzed data from a clinical trial that became available through litigation. Twenty-two cardiovascular events and 23 deaths occurred among patients who had taken rofecoxib in the trial, compared with six cardiovascular events and nine deaths among participants who took placebo.
###
(Arch Intern Med. 2010;170[22]:1968-1978, 1979-1986, 2035-2036. Available pre-embargo to the media at www.jamamedia.org.)
Editor's Note: The studies were funded by grants and contracts from the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services, as part of the Developing Evidence to Inform Decisions about Effectiveness (DECIDE) program. The project in the research letter was not supported by any external grants or funds. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
To contact Daniel H. Solomon, M.D., M.P.H., call Holly Brown-Ayers at 617-534-1603 or e-mail hbrown-ayers@partners.org.
For more information, contact JAMA/Archives Media Relations at 312/464-JAMA (5262) or e-mail mediarelations@jama-archives.org.
END
Personalized electronic messages to patients overdue for screenings, or mailings targeted to patients with expired orders for colonoscopies, may each increase colorectal cancer screening rates over the short term, according to two reports posted online today that will be published in the April 11 print issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Colorectal cancer is the second most common cause of cancer deaths in the United States, according to background information in the articles. "Colorectal cancer screening detects cancers at more ...
High levels of high-density lipoprotein (HDL), also known as "good" cholesterol, appear to be associated with a reduced risk for Alzheimer's disease in older adults, according to a report in the December issue of Archives of Neurology, one of the JAMA/Archives journals.
"Dyslipidemia [high total cholesterol and triglycerides] and late-onset Alzheimer's disease are highly frequent in western societies," the authors write as background information in the article. "More than 50 percent of the U.S. adult population has high cholesterol. About 1 percent of people age 65 to ...
African Americans and those with lower socioeconomic status appear to have more severe parkinsonism with greater levels of disability, according to a report posted online today that will appear in the April 2011 print issue of Archives of Neurology, one of the JAMA/Archives journals.
Parkinsonism (slow movements, tremor and rigidity) is a common condition among older U.S. adults, according to background information in the article. "The most common cause of parkinsonism is Parkinson's disease, a debilitating, chronic, progressive neurodegenerative disorder with an incidence ...
Acupuncture could potentially become an alternative to patching for treating amblyopia (lazy eye) in some older children, according to a report in the December issue of Archives of Ophthalmology, one of the JAMA/Archives journals.
About 0.3 percent to 5 percent of individuals worldwide have amblyopia, according to background information in the article. About one-third to one-half of the cases are caused by differences in the degree of nearsightedness or farsightedness between the two eyes, a condition known as anisometropia. Correcting these refractive errors with glasses ...
TEMPE, Ariz. – In 1986, Marc Reisner published "Cadillac Desert: The American West and its disappearing water," a foundational work about the long-term environmental costs of U.S. western state's water projects and land development. It sounded an alarm about the direction of the American West and how it was using its most precious resource. Now it all appears to becoming true.
Researchers applying modern scientific tools and mapping technologies, unavailable during Reisner's time, find his conclusions for the most part to be accurate and scientifically correct. As a ...
Sophia Antipolis, 14 December 2010: Today, heart failure is by far the single biggest reason for acute hospital admission. Around 30 million people in Europe have heart failure and its incidence is still increasing: more cases are being identified, more people are living to an old age, and more are surviving a heart attack but with damage to the heart muscle. Yet traditional risk-factor prediction models have only limited accuracy in this population to identify those at highest risk for worsening outcomes.
So far, those risk prediction models have relied on measurements ...
A new UC Davis study contradicts earlier reports that salmon farms were responsible for the 2002 population crash of wild pink salmon in the Broughton Archipelago of western Canada.
The Broughton crash has become a rallying event for people concerned about the potential environmental effects of open-net salmon farming, which has become a $10 billion industry worldwide, producing nearly 1.5 million tons of fish annually.
The new study, to be published online this week in Proceedings of the National Academy of Sciences, does not determine what caused the crash, but it ...
Researchers at King's College London have discovered that leukaemic stem cells can be reversed to a pre-leukaemic stage by suppressing a protein called beta-catenin found in the blood.
They also found that advanced leukaemic stem cells that had become resistant to treatment could be 're-sensitised' to treatment by suppressing the same protein.
Professor Eric So, who led the study at the Department of Haematology at King's College London, says the findings, published today in the journal Cancer Cell, represent a 'critical step forward' in the search for more effective ...
Deep sediment cores retrieved from the Bering Sea floor indicate that the region was ice-free all year and biological productivity was high during the last major warm period in Earth's climate history.
Christina Ravelo, professor of ocean sciences at the University of California, Santa Cruz, will present the new findings in a talk on December 13 at the fall meeting of the American Geophysical Union (AGU) in San Francisco. Ravelo and co-chief scientist Kozo Takahashi of Kyushu University, Japan, led a nine-week expedition of the Integrated Ocean Drilling Program (IODP) ...
DURHAM, N.C. – There are many mechanisms that alter the activity of genes – direct changes to the DNA code like mutations and deletions, or changes that control when genes are switched on and off, called epigenetic means. Tumor-suppressor genes are often inactivated through epigenetics, which provides an opening for the cancerous growth of cells.
Researchers at the Duke Cancer Institute have found evidence of epigenetics at work on a genome-wide scale in cases of ovarian cancer. One major biological signaling pathway in particular was found to contain many genes influenced ...
